BigBear.ai vs. D-Wave Quantum: Which Technology Stock Is a Better Buy in 2026?

The article favors BigBear.ai over D-Wave Quantum for 2026, citing BigBear's government-contract base, growing backlog and improving gross margins despite FY2025 revenue falling 19.3% to $127.7 million and a $293.9 million net loss. D-Wave posted 178.5% revenue growth to $24.6 million but lost $355.1 million, generated negative $75.8 million of free cash flow, and trades at a far higher 503.6x price-to-sales ratio versus BigBear's 10.5x. Both remain highly speculative and cash-burning; BigBear also faces customer concentration, accounting restatements and class-action litigation, while D-Wave faces commercialization and capital-raising risks.

Analysis

The relevant distinction is not "AI versus quantum" but contract-funded software deployment versus capital-intensive science commercialization. BBAI's government exposure can support multi-year renewal economics and higher switching costs, but its accounting restatement means backlog, gross-margin improvement, and cash-burn claims should be treated as unverified until revised filings reconcile prior periods. A clean restatement could remove a governance discount over 1-3 months; a further delay or control weakness would likely overwhelm any contract-win narrative.

QBTS requires an exceptionally steep conversion of bookings and pilot relationships into recurring revenue to justify its valuation. Enterprise logos are not proof of production deployment: customers can run low-dollar proof-of-concepts while retaining the option to use classical optimization, Nvidia GPUs, or hyperscaler quantum services. The second-order beneficiary of rising quantum experimentation is more likely MSFT, which can monetize cloud consumption regardless of which quantum architecture wins, whereas QBTS bears hardware utilization, R&D, and future-dilution risk.

Consensus may be too willing to call BBAI "defensive" because it serves federal customers. Procurement concentration makes quarterly revenue lumpy, and delayed appropriations or program reprioritization can create a working-capital shock even without contract loss. Conversely, QBTS can squeeze sharply on bookings, technical milestones, or capital raises that extend its cash runway; fundamental shorts should be structured as pairs and sized for meme-stock volatility rather than as standalone valuation bets.

Near term, neither name offers a clean earnings-quality long until cash burn, diluted share count, and revenue-recognition disclosures are independently confirmed. Over 6-18 months, BBAI's upside depends on converting classified-program access into repeatable, higher-margin software revenue; QBTS's depends on commercial workloads becoming recurring rather than experimental. The decisive data points are BBAI's restated financials and operating cash flow, versus QBTS's recurring cloud revenue, backlog-to-revenue conversion, and quarterly dilution.

Key Decisions for Investors

• Watch, do not initiate an outright BBAI long before restated filings: enter only if the restatement is timely, no material contract-revenue reversal emerges, and two consecutive quarters show improving operating-cash-flow conversion. Falsifier: another filing delay, material control deficiency, or renewed FCF deterioration; this is a 1-6 month event-driven setup.
• Express relative quality with a small long BBAI / short QBTS pair only after the BBAI filing clears, using equal dollar exposure and a 2-3% portfolio gross-risk cap. Target a 15-25% relative move over 3-6 months from multiple compression in QBTS or a BBAI governance rerating; cover if QBTS reports sustained recurring revenue acceleration or BBAI revises backlog/revenue guidance lower.
• For quantum-theme exposure, prefer MSFT over QBTS on a 6-18 month horizon: MSFT captures cloud and enterprise experimentation demand while avoiding single-architecture and financing risk. Reassess if QBTS demonstrates recurring commercial revenue growth that materially outpaces dilution for two quarters.
• Set alerts around QBTS quarterly filings for shares outstanding, cash usage, deferred revenue, and cloud-service mix rather than headline bookings. A financing that extends runway without a corresponding improvement in recurring revenue should be treated as a short-term liquidity relief rally, not thesis validation.